From: Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases
Regulatory mechanisms | piRNA/PIWI | Expression | Diseases | Targets/signaling pathway | In vitro | In vivo | Ref. |
---|---|---|---|---|---|---|---|
Abnormal cell cycle and Resistance to apoptosis | piR-823 | up | Colorectal cancer | HSF1 | Promote cell cycle and inhibit cell apoptosis | NA | [90] |
piR-017061 | down | Pancreatic cancer | ERK signaling pathway | Inhibit cell growth and induce apoptosis | Attenuate the volumes and weights of the xenografts in vivo | [91] | |
piR-36,712 | down | Breast cancer | P53 signaling pathway | Suppress cell proliferation, migration and invasion | Lower tumor growth rate | [92] | |
piR-004800 | up | Multiple Myeloma | PI3K/Akt/mTOR Pathway | Promote proliferation and inhibit apoptosis and autophagy | Promote MM proliferation | [93] | |
piR-8041 | down | Glioblastoma | NA | Induce cell cycle arrest and apoptosis | Restrict tumor growth temporarily | [94] | |
PIWIL1 | up | Glioblastoma | CDKN1B and CCND2 | PIWIL1 knockdown causes cell cycle arrest, and induces apoptosis and promotes senescence. | PIWIL1 Knockdown reduces Tumor Growth and improves survival | [95] | |
piR-30,188/PIWIL3 | down | Glioblastoma | OIP5-AS1/miR-367/CEBPA/TRAF4 pathway | Suppress tumor cell proliferation, invasion, and migration, and promotes apoptosis | Restrain tumor growth and prolong nude mice survival | [96] | |
piR-651 | up | Non-small cell lung carcinoma | Cyclin D1 and CDK4 | Promote cell cycle progression in G2/M phase | Promote tumor growth | [97] | |
piR-651 | up | Non-small cell lung carcinoma | Mitochondria-dependent pathway | Promote cell proliferation in a time-dependent manner and inhibits apoptosis, Promote NSCLC cell migration and invasion | NA | [98] | |
PIWIL2 | up | Esophageal squamous cell carcinoma | NF-κB signaling pathway | Promote cell proliferation, inhibit apoptosis, and activate autophagy | Promote tumor growth | [99] | |
Aberrant proliferative signaling pathways | piR-31,115 | up | Clear cell renal cell carcinoma | PI3K/AKT Pathway | Promote cell proliferation, invasion and metastasis | NA | [100] |
piR-001773 and piR-017184 | up | Prostate cancer | PI3K/AKT Pathway | Promote cell growth, invasion, and migration | Promote PCa cell growth, invasion, and migration | [101] | |
piRNA-823 | up | Luminal breast cancer | Wnt/β-catenin signaling pathway | Acquire stem cell-like properties, promote cell proliferation | Promote tumor growth | [102] | |
piR-55,490 | down | Lung cancer | Akt/mTOR pathway | Reduce the proliferation | Suppress the growth of xenografts | [103] | |
Activation of invasion and metastasis | piR-57,125 | down | Clear cell renal cell carcinoma | AKT/ERK signaling pathway | Restrain cell metastasis | Knockdown of piR-57,125 promotes ccRCC cells metastasis | [104] |
piR-19,166 | down | Prostate carcinoma | CTTN/MT1-MMP/MMP2/MMP9 signaling pathway | Hinder cell migration | Reduce the number and size of metastatic nodules | [105] | |
piR-39,980 | up | Osteosarcoma | MMP2 | Induce the proliferation and enhance the invasion and metastasis | NA | [106] | |
piR-54,265 | up | Colorectal cancer | MMP2 and MMP9 | Promote proliferation, migration and invasion | Promote tumor growth, spread and metastasis. | [107] | |
PIWIL2 | up | Prostate cancer | MMP9 | PIWIL2 knockdown weakened tumor cell invasion and migration | NA | [108] | |
PIWIL1 | up | Pancreatic cancer | Pinin | Increase the proliferation, invasion and metastasis | Promote growth and metastasis of xenografts | [109] | |
piRNA-823 | up | Multiple myeloma | VEGF and IL-6 | Promote angiogenesis and invasion | Promote the growth of xenograft tumors | [110] | |
piRNA-823 | up | Multiple myeloma | VEGF | Promote proangiogenic activity | Promote the growth of xenograft tumors | [111] | |
EMT | piR-17,560 | up | Breast cancer | FTO/ZEB1 signaling pathway | Promote the proliferation, EMT and chemoresistance | Increase tumor volume under chemotherapy drug treatment | [112] |
piR-31,115 | up | Clear cell renal cell carcinoma | NA | Promote migration and invasion | NA | [100] | |
PIWIL1 | up | Endometrial cancer | NA | Endow endometrial cancer [EC] cells with stem-like properties, such as tumor cell viability, migration, invasion, and sphere-forming activity. | Increase tumor growth | [113] | |
piR-1037 | up | Oral squamous cell carcinoma | NA | Enhance the motility | Increase tumor growth | [114] | |
Energy metabolism | piR-823 | up | Colorectal cancer | PINK1-Parkin mediated mitophagy | Maintain mitochondrial function, dynamics, and quantity | Block mitophagy, increases tumor volume and tumor weight | [115] |
piR-hsa-211,106 | down | Lung Adenocarcinoma | Pyruvate carboxylase | Attenuate cell proliferation and colony formation | Suppress tumor xenograft growth | [116] | |
PIWIL2 | up | Radiation-induced pulmonary fibrosis | Purine metabolism | Activate purine metabolism and promote the attenuation of RILF | Alleviate pulmonary fibrosis | [117] | |
PIWIL1 | up | Hepatocellular carcinoma | MLYCD | Induce fatty acid metabolism | Promote the tumor growth | [118] | |
DNA damage | piR-39,980 | down | Fibrosarcoma | RRM2 | Enhance apoptosis of fibrosarcoma cells induced by DOX treatment | NA | [119] |
PIWIL4 | down | Fibrosarcoma | ROS accumulation | Reduce cell growth, migration and invasion | NA | [120] | |
piR-31,470 | up | Prostate cancer | GSTP1 | Promote call proliferation | NA | [121] | |
Immune microenvironment | PIWIL4 | up | HIV-1 Latency | SETDB1、HP1α/β/γ | Maintains HIV-1 latency in infected CD4 + T lymphocytes and inhibits viral replication | NA | [122] |
PIWIL1 | up | Hepatocellular carcinoma | IL10 | Inhibition of immune response in the tumor microenvironment | promotes the tumor growth | [118] | |
piR-DQ551351 | down | Prostate cancer | M2 macrophages polarization | NA | inhibit tumor growth | [123] | |
piR-DQ551309 | up | Prostate cancer | M2 macrophages polarization | NA | inhibit tumor growth | [123] |